drugset / Trial / NCT02228590
A Study to Examine APL-130277 in Patients With Parkinson's Disease
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to evaluate the efficacy, tolerability and safety of single treatments of APL-130277 in 16 patients with Parkinson's Disease (PD)
Timeline
- Start
- 2014-08-31
- Primary completion
- 2014-11-24
- Completion
- 2014-11-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | APL-130277 | Unknown | — | Other |